Search the Newsreel

Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales

Carlsmed Inc. (CARL) has filed a shelf registration to offer up to $250 million in common stock, preferred stock, debt securities, warrants, and units. This filing allows the medical technology company to access capital markets for future funding, with specific terms for each issuance …

Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis

CervoMed (CRVO) holders CVI and Heights report 0% stake in amended filing

CVI Investments, Inc. and Heights Capital Management, Inc. have filed an amended Schedule 13G/A for CervoMed Inc. (CRVO), reporting a 0% beneficial ownership in the company. This filing indicates that both entities collectively hold no shares and possess no voting or dispositive power over …

Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?

Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …

National CineMedia (NCMI): Orbis and Allan Gray disclose 9.9% beneficial stake in amended 13G

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed an amended 13G filing for National CineMedia, Inc. (NCMI), reporting a combined beneficial ownership of 9.9% of the company's common stock, totaling 9,313,977 shares. Orbis holds sole voting and dispositive power …

Blue Ant Media Corporation — TSX:BAMI Jumps 4.58%: Can Strong Production Growth and Global Streaming Expansion Drive a New Growth Phase?

Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.5% ownership stake in Praxis Precision Medicines (PRAX), amounting to 1,529,788 shares of common stock as of June 30, 2026. Orbis holds the majority with 1,526,680 shares, while Allan Gray …

(PRAX) and the Role of Price-Sensitive Allocations

This article provides a detailed AI-driven analysis of Praxis Precision Medicines Inc. (NASDAQ: PRAX), highlighting a strong overweight bias across all time horizons. It outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report …

TransMedics Group, Inc. Investor News: Rosen Law Firm

The Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by the directors and officers of TransMedics Group, Inc. (NASDAQ: TMDX). The firm is encouraging shareholders of TransMedics Group to visit its website or contact them for more information regarding …

Susquehanna group reports 5.3% Medifast (MED) ownership in Schedule 13G

Susquehanna Portfolio Strategies, LLC and Susquehanna Securities, LLC have collectively reported a 5.3% beneficial ownership stake in Medifast (MED) through a Schedule 13G filing. This amounts to 587,214 shares of Medifast common stock as of June 30, 2026, including options for 542,700 shares held …

Brandes Investment Partners reports 14.9% Utah Medical Products (UTMD) stake

Brandes Investment Partners has filed an amended Schedule 13G, disclosing a 14.92% passive ownership stake in Utah Medical Products Inc., totaling 475,158 common shares. These shares are held across mutual funds and other accounts advised by Brandes, with the Brandes Small Cap Value Fund …

Why Blue Ant Media Corporation stock is rising today

Medicenna Therapeutics Corp. Reports Earnings Results for the First Quarter Ended June 30, 2026

Preformed Line Products (PLPC) Looks Pricey On A 29% 1 Month Run

Preformed Line Products (PLPC) has experienced a significant share price increase of 29% over the past month and three months, reaching a year-to-date gain of 111% and a 1-year total shareholder return of 144%. Despite this strong momentum, the stock appears richly valued with …

Aquamarine Financial (ORMP) discloses 6.04% Oramed ownership in 13G/A

Aquamarine Financial (Cayman) Ltd has reported a beneficial ownership of 2,512,175 shares in Oramed Pharmaceuticals Inc., which constitutes 6.04% of the common stock as of June 30, 2026. The filing, an amended Schedule 13G/A, indicates that Aquamarine holds sole voting and sole dispositive power …

Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy?

Alpha Tau Medical (DRTS) reported a significant widening of its net loss to US$68.75 million in the first half of 2026, up from US$18.81 million a year prior, leading to increased concerns about its funding risk. Despite the company's focus on clinical progress for …

Royal Bank Of Canada Issues Positive Forecast for CorMedix (NASDAQ:CRMD) Stock Price

Why Shares of Trump Media & Technology Stock Sank 18% This Week

Shares of Trump Media & Technology (NASDAQ: DJT) fell 18.1% this week, according to data from S&P Global Market Intelligence. The holding company for the Trump family media businesses reported earnings earlier this week, posting large losses on its cryptocurrency assets as it searches …

What's Going On With Medipharm Labs Corp Stock Friday?

Solas Capital discloses 9.99% Modular Medical (MODD) position via stock and warrants

Solas Capital Management, LLC and Frederick Tucker Golden have reported an amended beneficial ownership of 9.99% in Modular Medical, Inc. (MODD). This stake comprises 552,171 shares, including common stock and shares issuable upon warrant exercise, with shared voting and dispositive power. The filing details …

ResMed (RMD) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Investor Relations Officer-Salli Schwartz Chairman and Chief Executive Officer-Mick Farrell Chief Financial Officer-Aaron Bloomer Full Conference Call Transcript Operator: Hello, and welcome to the Q4 Fiscal Year …

Shanghai HeartCare Seeks Shareholder Approval for Sci-Tech Board A-Share Issuance

Shanghai HeartCare Plans A Share Issue and Sci-Tech Board Listing

ICU Medical (ICUI) Insider Sells 5,417 Shares: VP, GM-Infusion Capital Daniel Woolson Reduces Stake

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc (ICUI), sold 5,417 shares of the company on August 13, 2026, bringing his total ownership to 17,062 shares. This transaction is part of a trend where insiders at ICU Medical have generally been selling more …

PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

PetMed Express (PETS) reported first-quarter fiscal 2027 results, missing Zacks Consensus Estimates for both top and bottom lines, with sales declining year-over-year. Despite the decline in sales and widened Adjusted EBITDA loss, the company narrowed its loss per share and focused on improving customer …

AJJ Medtech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Fischer Medical Ventures Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Why Medipharm Labs Corp stock is skyrocketing today

T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock

T. Rowe Price Associates has reported a 5.0% beneficial ownership in Mediwound Ltd. common stock, totaling 641,075 shares as of June 30, 2026. The firm holds sole voting power over 638,398 shares and sole dispositive power over all 641,075 shares, with no shared voting …

Form 8K PAVmed Inc For: 14 August By Investing.com

This article from Investing.com is a regulatory filing notification, specifically a Form 8K for PAVmed Inc. The brief content indicates that the filing was made on August 14th and the article itself was published on the same date. The article is very short and …

Sell Alert: Daniel Woolson Cashes Out $982K In ICU Medical Stock

Daniel Woolson, VP at ICU Medical (NASDAQ: ICUI), recently sold 5,417 shares of the company's stock for a total transaction value of $982,264, as disclosed in an SEC filing. This insider transaction occurred on August 13, leading to a slight dip in ICU Medical's …

Armistice Capital (OFIX) discloses 3.26M-share, 8.01% Orthofix Medical stake

Armistice Capital, LLC and Steven Boyd have reported an updated beneficial ownership stake of 8.01% in Orthofix Medical Inc., totaling 3,264,000 shares. This disclosure, made via an Amendment No. 8 to their Schedule 13G, indicates shared voting and dispositive power over these shares, which …

Mobia Medical, Inc. - Common Stock MOBI

Mobia Medical, Inc. (NASDAQ:MOBI) reported strong second-quarter results with revenue reaching $13.5 million, marking a 102% increase year-over-year. This growth is attributed to the expanded adoption of its Vivistim paired vagus nerve stimulation therapy within stroke-care programs.

Armistice Capital reports 9.99% ownership of Tenon Medical (TNON) through Master Fund

Armistice Capital, LLC and Steven Boyd have reported a 9.99% beneficial ownership stake in Tenon Medical, Inc. (TNON) through Armistice Capital Master Fund Ltd. This ownership, totaling 54,554 shares, grants them shared voting and dispositive power. The filing specifies that the Master Fund retains …

Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power

Woodline Partners LP has reported a beneficial ownership of 8.1% in CalciMedica, Inc., totaling 2,489,729 shares of common stock. The investment firm, acting as an adviser to Woodline Master Fund LP, holds sole voting and dispositive power over these shares. This disclosure, made via …

Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership stake of 6,364,000 shares in Treace Medical Concepts, Inc. (TMCI), representing 9.79% of the outstanding common stock. This ownership is held directly by Armistice Capital Master Fund Ltd., with Armistice Capital serving as …